BACKGROUND AND PURPOSE: Use of statin medications has been demonstrated to
improve clinical and angiographic outcomes in patients receiving endovascular stent …

Background: Several pharmacological pathways have revealed statin to have a positive role
in patients with for intracranial aneurysms. However, prior studies regarding the association …

Background The effect of statins and diabetes on angiographic and clinical outcomes in
aneurysms treated with pipelines has not been adequately reported. Our aim is to assess …

Background Flow-diverting (FD) stents, with or without coiling, are a mainstay in
endovascular treatment of intracranial aneurysms (IAs). One observed complication from …

OBJECTIVE Cerebral aneurysms represent the most common cause of spontaneous
subarachnoid hemorrhage. Statins are lipid-lowering agents that may expert multiple …

Background Owing to their anti-inflammatory effects and ability to stimulate production of
extracellular matrix and chemotactic migration of mesenchymal progenitor cells, statins …

BACKGROUND AND PURPOSE: Smoking is a major risk factor for patients with intracranial
aneurysms, yet the effects of smoking on outcomes of aneurysm with flow-diverter treatment …

BACKGROUND: In-stent stenosis (ISS) is a delayed complication that can occur after
pipeline embolization device use when treating intracranial aneurysms (IAs). OBJECTIVE …

BACKGROUND AND PURPOSE: Risk factors for acute ischemic stroke following flow-
diverter treatment of intracranial aneurysms are poorly understood. Using the International …

BACKGROUND AND PURPOSE: Spontaneous intraparenchymal hemorrhage is a dreaded
complication of unknown etiology following flow-diversion treatment. Using the International …